Patents by Inventor Xianlei FU

Xianlei FU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrimidine-fused cyclic compound, preparation method therefor and application thereof
    Patent number: 11498930
    Abstract: Disclosed in the present disclosure are a pyrimidine-fused cyclic compound or a pharmaceutically acceptable salt, hydrate, prodrug, stereoisomer, solvate or isotope labeled compound thereof. Also provided in the present disclosure are a preparation method for the compound, a composition comprising the compound and a use of the compound for the preparation of a medicament for the prevention and/or treatment of a disease or condition associated with abnormal SHP2 activity.
    Type: Grant
    Filed: February 3, 2019
    Date of Patent: November 15, 2022
    Assignee: BLUERAY THERAPEUTICS (SHANGHAI) CO., LTD
    Inventors: Bin Zou, Xianlei Fu, Rui Zhang, Shichao Ma, Shuaijie Xu, Wencheng Fu, Lanzhen Liu
  • PYRIMIDINE-FUSED CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
    Publication number: 20210053989
    Abstract: Disclosed in the present disclosure are a pyrimidine-fused cyclic compound or a pharmaceutically acceptable salt, hydrate, prodrug, stereoisomer, solvate or isotope labeled compound thereof. Also provided in the present disclosure are a preparation method for the compound, a composition comprising the compound and a use of the compound for the preparation of a medicament for the prevention and/or treatment of a disease or condition associated with abnormal SHP2 activity.
    Type: Application
    Filed: February 3, 2019
    Publication date: February 25, 2021
    Inventors: Bin ZOU, Xianlei FU, Rui ZHANG, Shichao MA, Shuaijie XU, Wencheng FU, Lanzhen LIU
  • Compound having mutant IDH inhibitory activity, preparation method and use thereof
    Patent number: 10682352
    Abstract: Provided in the present invention are a compound having the effects of preventing and treating diseases related to IDH mutation, and a preparation method and use thereof.
    Type: Grant
    Filed: March 21, 2017
    Date of Patent: June 16, 2020
    Assignees: SHANGHAI HAIHE PHARMACEUTICAL CO., LTD., SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    Inventors: Lei Jiang, Meiyu Geng, Qiangang Zheng, Min Huang, Huixin Wan, Shuai Tang, Xianlei Fu, Xiaojing Lan, Jianhua Cao, Feifei Liu, Jian Ding
  • COMPOUND HAVING MUTANT IDH INHIBITORY ACTIVITY, PREPARATION METHOD AND USE THEREOF
    Publication number: 20190111056
    Abstract: Provided in the present invention are a compound having the effects of preventing and treating diseases related to IDH mutation, and a preparation method and use thereof.
    Type: Application
    Filed: March 21, 2017
    Publication date: April 18, 2019
    Inventors: Lei JIANG, Meiyu GENG, Qiangang ZHENG, Min HUANG, Huixin WAN, Shuai TANG, Xianlei FU, Xiaojing LAN, Jianhua CAO, Feifei LIU, Jian DING